Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Rafat

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Kidney International|October 26, 2019
IdeS in anti-glomerular basement membrane disease: Is this the new deal?Cédric Rafat, Yosu Luque
Kidney International Reports|August 12, 2020
Eculizumab and aHUS: Spotlight on Patient-Centered CareCédric Rafat, Yosu Luque
Kidney International|August 21, 2022
Could Plasmodium falciparum-related kidney disease stand as another example of interferonopathy?Cédric Rafat, Alice Doreille
Expert Review of Clinical Immunology|October 26, 2019
Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginningCédric Rafat, Yosu Luque
La Revue Du Praticien|April 7, 2015
[Elevated serum creatinine]Cédric Rafat, Alexandre Hertig
La Revue Du Praticien|June 23, 2021
[Acute renal failure and cancer treatment]Cédric Rafat, Hugo Garcia, Steven Grangé
The New England Journal of Medicine|December 29, 2017
Angiotensin II for the Treatment of Vasodilatory ShockMatthieu Jamme, Alexandre Hertig, Cédric Rafat
Expert Opinion on Pharmacotherapy|April 26, 2013
Levofloxacin for the treatment of pyelonephritisCédric Rafat, Isabelle Debrix, Alexandre Hertig
Kidney International Reports|July 31, 2024
Response to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition": Still a Long Way to GoCédric Rafat, Laurent Mesnard, Yosu Luque
Kidney International|July 16, 2017
Complement-dependent, monoclonal gammapathy-associated thrombotic microangiopathyJuliet Schurder, Cédric Rafat, Clara Vigneron
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Kidney International|October 26, 2019
IdeS in anti-glomerular basement membrane disease: Is this the new deal?Cédric Rafat, Yosu Luque
Kidney International Reports|August 12, 2020
Eculizumab and aHUS: Spotlight on Patient-Centered CareCédric Rafat, Yosu Luque
Kidney International|August 21, 2022
Could Plasmodium falciparum-related kidney disease stand as another example of interferonopathy?Cédric Rafat, Alice Doreille
Expert Review of Clinical Immunology|October 26, 2019
Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginningCédric Rafat, Yosu Luque
La Revue Du Praticien|April 7, 2015
[Elevated serum creatinine]Cédric Rafat, Alexandre Hertig
La Revue Du Praticien|June 23, 2021
[Acute renal failure and cancer treatment]Cédric Rafat, Hugo Garcia, Steven Grangé
The New England Journal of Medicine|December 29, 2017
Angiotensin II for the Treatment of Vasodilatory ShockMatthieu Jamme, Alexandre Hertig, Cédric Rafat
Expert Opinion on Pharmacotherapy|April 26, 2013
Levofloxacin for the treatment of pyelonephritisCédric Rafat, Isabelle Debrix, Alexandre Hertig
Kidney International Reports|July 31, 2024
Response to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition": Still a Long Way to GoCédric Rafat, Laurent Mesnard, Yosu Luque
Kidney International|July 16, 2017
Complement-dependent, monoclonal gammapathy-associated thrombotic microangiopathyJuliet Schurder, Cédric Rafat, Clara Vigneron
Pageof 9